BOLD vs CB
Boundless Bio, Inc. Common Stock (BOLD) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the BOLD and CB stock pages for the full models.
Not investment advice.